Abstract:<h3 class="article-section__sub-title section1"> Objective</h3><p>While the role of antiphospholipid antibodies in activating endothelial cells has been extensively studied, the impact of these antibodies on the adhesive potential of leukocytes has received less attention. Here, we investigated the extent to which antiphospholipid syndrome (APS) neutrophils adhered to resting endothelial cells under physiologic flow conditions, as well as the surface molecules required for that adhesion.</p><h3 class="article-section__sub-title section1"> Methods</h3><p>Patients with primary APS (n=43), patients with history of venous thrombosis but negative testing for antiphospholipid antibodies (n=11), and healthy controls (n=38) were studied. Cells were introduced into a flow chamber and perfused across resting human umbilical vein endothelial cell (HUVECs). Surface adhesion molecules were quantified by flow cytometry. Neutrophil extracellular trap (NET) release (NETosis) was assessed in neutrophil‐HUVEC co‐cultures.</p><h3 class="article-section__sub-title section1"> Results</h3><p>Upon perfusion of anticoagulated blood through the flow chamber, APS neutrophils demonstrated increased adhesion as compared with control neutrophils under conditions representative of either venous (n=8, p<0.05) or arterial (n=15, p<0.0001) flow. At the same time, APS neutrophils were characterized by upregulation of CD64, CEACAM1, beta‐2 glycoprotein I, and activated Mac‐1 on their surface (n=12‐18, p<0.05 for all markers). Exposing control neutrophils to APS plasma or APS IgG resulted in increased neutrophil adhesion (n=10‐11, p<0.001) and surface marker upregulation as compared with controls. A monoclonal antibody specific for activated Mac‐1 reduced the adhesion of APS neutrophils in the flow‐chamber assay (p<0.01). The same monoclonal antibody reduced NETosis in neutrophil‐HUVEC co‐cultures (p<0.01).</p><h3 class="article-section__sub-title section1"> Conclusion</h3><p>APS neutrophils demonstrate increased adhesive potential, which is dependent upon the activated form of Mac‐1. In patients, this could lower the threshold for neutrophil‐endothelium interactions, NETosis, and possibly thrombotic events.</p><p>This article is protected by copyright. All rights reserved.</p>

5-oxoETE promote thrombosis in antiphospholipid syndrome by triggering NETs formation through PLC/PKC/ERK pathway

Antiphospholipid antibody‐activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome

Anti–Neutrophil Extracellular Trap Antibodies and Impaired Neutrophil Extracellular Trap Degradation in Antiphospholipid Syndrome

Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome

Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome

NEUT-RI, a surrogate marker of NETosis is lower in patients with strong IgM antiphospholipid antibodies

Targeting thromboinflammation in antiphospholipid syndrome

Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome

Lysophosphatidic acid promotes thrombus stability by inducing rapid formation of neutrophil extracellular traps: A new mechanism of thrombosis

H3K4me3‐Mediated FOXJ2/SLAMF8 Axis Aggravates Thrombosis and Inflammation in Β2gpi/anti‐β2gpi‐treated Monocytes

Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome

Activation of Platelet Mtorc2/akt Pathway by Anti-β2GP1 Antibody Promotes Thrombosis in Antiphospholipid Syndrome.

Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome

LTB4 and 5-oxo-ETE from extracellular vesicles stimulate neutrophils in granulomatosis with polyangiitis

Insight into antiphospholipid syndrome: the role and clinical utility of neutrophils extracellular traps formation

Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts

Interaction of antiphospholipid antibodies with endothelial cells in antiphospholipid syndrome

Increased Adhesive Potential of Antiphospholipid Syndrome Neutrophils Mediated by β2 Integrin Mac‐1

Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke

Epigenetics-mediated pathological alternations and their potential in antiphospholipid syndrome diagnosis and therapy.

Altered platelet proteome in lupus anticoagulant (LA)-positive patients—protein disulfide isomerase and NETosis as new players in LA-related thrombosis